Accelerate Diagnostics Cash Flow - Annual (NASDAQ:AXDX)

Add to My Stocks
$24.45 $0.25 (1.03%) AXDX stock closing price Feb 22, 2017 (Closing)

The Accelerate Diagnostics cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows Accelerate Diagnostics profits, the balance sheet shows Accelerate Diagnostics debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Accelerate Diagnostics stock analysis. Accelerate Diagnostics generated $-35.12M cash from operating activities in 2015. AXDX increase in investments stood at a negative value of $-2.67M for the latest 2015. View details of Accelerate Diagnostics cash flows for latest & last ten financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007
Accelerate Diagnostics Net Income Cash Flow
-45.49M-30.93M-15.28M--0.43M0.06M-0.41M-0.22M-0.48M
Depreciation Depletion Amortization Cash-Flow1.98M1.15M0.43M-0.06M0.06M0.06M0.06M0.07M
Net Increase (Decrease) in Assets Liabilities-1.36M1.25M--0.01M-0.16M0.04M-0.06M0.16M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net8.38M9.62M3.83M-0.27M-0.01M-0.14M-0.01M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
-35.12M-18.78M-9.74M--0.09M-0.04M-0.3M-0.06M-0.25M
Increase (Decrease) in Prop Plant And Equipment-3.65M-1.93M-1.15M------
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments0.98M-1.43M-12.01M-----0.01M-
Other Cash Inflow (Outflow) from Investment Activities-----0.08M-0.01M-0.08M-0.07M-0.11M
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
-2.67M-3.37M-13.17M--0.09M-0.01M-0.08M-0.08M-0.11M
Issuance (Purchase) of Equity Shares104.97M45.79M40.88M------
Issuance (Repayment) of Debt Securities-0.14M-0.1M-------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities
Accelerate Diagnostics Net Cash from (used by) Financing Activities
104.82M45.69M40.88M------
Effect of Exchange Rate Changes on Cash---------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
67.02M23.53M17.96M--0.19M-0.06M-0.39M-0.15M-0.36M
Cash & Equivalents at Beginning of Year53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End120.58M53.56M30.02M-0.58M0.22M0.47M1.08M1.02M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

1:25
AXDX
The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Accelerate Diagnostics stock price history and Accelerate Diagnostics stock comparison chart inevitably reflect its cash flow situation.
  • Accelerate Diagnostics saw an increase in Net Change in Cash and Cash Equivalents from $23.53M in 2014 to $67.02M in 2015. Apart from the Accelerate Diagnostics stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Accelerate Diagnostics decreased its cash from operating activities to $16.34M in 2015. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-35.12M for AXDX in last year report.
  • Cash flow from financing activities shows the flow of cash between Accelerate Diagnostics and its owners and creditors and was $104.82M for 2015. Financing activities allow a company to raise capital, and repay bondholders.
.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin
-637